Matthew Baker - Biog

 

Dr Baker completed a PhD in cellular immunology at University of Birmingham UK and after two postdoctoral positions in Cambridge moved to the biotechnology industry where he has held senior management positions at a number of companies including Biovation, Cellular Technologies Limited and Whatman BioSciences.  Dr Baker is a founder and the Chief Scientific Officer of Antitope a Cambridge, UK based company which specializes in the prediction of immunogenicity in biologics.